Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01587092
Other study ID # PBRC 12015
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 2012
Est. completion date February 2013

Study information

Verified date September 2022
Source Pennington Biomedical Research Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a pilot study to assess the feasibility of using treadmill desks (Workstations) within a Louisiana office workplace and to determine the effects of walking while working in overweight or obese, sedentary individuals.


Description:

Eligible participants will be randomized by chance to the WorkStation Intervention Group or to a Usual Working Condition Group. The WorkStation Intervention Group will be asked to walk for up to 1.5 hours per day during the work week of Monday through Friday on the treadmill. Participants will complete two sessions per day for up to 45 minutes per session, tracking time and speed. Usual Working Condition Group will be asked to continue working in usual environment and accustomed manner. Regardless of which group the participants are assigned to, the participants will be asked to complete baseline and follow up assessment visits. Months 3 and 6 for approximately 1 hour for Body measurements (height, weight and waist circumference), body fat percent, gait speed, questionnaires, and accelerometry.


Recruitment information / eligibility

Status Completed
Enrollment 41
Est. completion date February 2013
Est. primary completion date February 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Males or females - BMI = 25 kg/m2 - Willing to give informed consent - Willing to accept randomization to group assignment and willing to follow the protocol for the group to which they have been assigned - Willing to maintain fulltime employment at the company for the next 6 months - Willing to receive frequent contacts and communication from study staff over the next 6 months Exclusion Criteria: - Current participation in other Pennington Biomedical research studies - BMI < 25 kg/m2 - Type 1 diabetes - Average step count of = 7,500 steps/day - Self-reporting exercising > 20 minutes on 3 or more days/wk, within the past 6 months - Unable to walk 45 minutes continuously without taking a rest - Unable to walk without the use of an assistive device, such as a cane or walker - Have had a cardiovascular event (stroke or heart attack) in the past 6 months - Have a pacemaker or any other internal electrical medical device - Have been diagnosed with Schizophrenia or bipolar disorder - Have any condition that would limit participation in a physical activity program - Women who are pregnant, have been pregnant in the last 6 months, or are breastfeeding - Actively participating in a weight loss program - Plan to move out of the study area within the next 6 months or plan to be away from work for more than 4 weeks in the next 6 months - Have another member of household participating in the study - Have any condition, which, in the opinion of the investigator would impede competence or compliance or possibly hinder completion of the study

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
WorkStation
Participants will be asked to attend 2 scheduled sessions per day of treadmill walking, which will replace their sitting desk time. Participants will complete 2 sessions per day for 6 months.
Usual Working Condition
Participants will be asked to continue working at their desk in their usual manner.

Locations

Country Name City State
United States Pennington Biomedical Research Center Baton Rouge Louisiana

Sponsors (1)

Lead Sponsor Collaborator
Pennington Biomedical Research Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Waist Waist circumference will decrease in workers assigned to the WorkStation working condition relative to the usual working condition. 6 months
Secondary Weight Assessments Weight will improve in workers assigned to the WorkStation Group relative to the Usual Working Condition Group. 6 months
Secondary Body Fat Percent Body fat percent will improve in workers assigned to the WorkStation Group relative to the Usual Working Condition Group. 6 months
Secondary Accelerometry Participants' activity level measured by the accelerometer will increase in workers assigned to the WorkStation Group relative to the Usual Working Condition Group. 6 months
Secondary Gait Speed Participants' gait speed will improve in workers assigned to the WorkStation Group relative to the Usual Working Condition Group. 6 months
Secondary Stress Participants' stress level will decrease in workers assigned to the WorkStation Group relative to the Usual Working Condition Group. 6 months
Secondary Fatigue Participants' fatigue level will decrease in workers assigned to the WorkStation Group relative to the Usual Working Condition Group. 6 months
Secondary Quality of life Questionnaire Participants' quality of life will improve in workers assigned to the WorkStation Group relative to the Usual Working Condition Group. 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2